Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

Background Liver cirrhotic patients with nonvalvular atrial fibrillation have been excluded from randomized clinical studies regarding oral anticoagulants for stroke prevention. Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior to warfarin for these patients remains unclear....

Full description

Bibliographic Details
Main Authors: Hsin‐Fu Lee, Yi‐Hsin Chan, Shang‐Hung Chang, Hui‐Tzu Tu, Shao‐Wei Chen, Yung‐Hsin Yeh, Lung‐Sheng Wu, Chang‐Fu Kuo, Chi‐Tai Kuo, Lai‐Chu See
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
direct thrombin inhibitor
factor Xa inhibitor
hemorrhage
ischemic stroke
liver cirrhosis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.011112

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.011112

Similar Items